Analysis of the Antigenic Properties of Membrane Proteins of Mycobacterium tuberculosis

Tuberculosis (TB) is a continuing major threat to global health and a leading cause of death, particularly in developing countries. In this study, we aimed to identify a specific and sensitive diagnostic biomarker and develop a vaccine to prevent this disease. We investigated membrane proteins to reveal biomarkers in serum and peripheral blood mononuclear cells (PBMCs) obtained from TB patients. We employed Western blotting to evaluate serological immunoglobulin G levels, and Enzyme Linked Immunospot (ELISpot) to assess the antigen-specific cellular interferon-γ secretion from PBMCs after membrane protein stimulation. A total of 219 membrane proteins were identified, 52 exhibited at a higher levels than the 38-kDa prositive control. Of these 18 exhibited reacted ratios above 1, especially Rv1111c (427–981), with a ratios at 3.38. Accuracy and sensitivity were markedly higher for the top two antigen candidates, Rv0232 and Rv1115, after two rounds of ELISpot tests than ESAT-6 in the commercial kit (42.15 and 43.62%, respectively). These two proteins were administered to mice to detect whether they acted as effective antigens in vivo. These data provide a comprehensive view of the membranes involved in humoural and cellular immune responses that may be used as biomarkers for TB and candidates for a vaccine.

[1]  M. Pai,et al.  Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection , 2014, Clinical Microbiology Reviews.

[2]  W. Lu,et al.  Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study. , 2017, The Lancet. Infectious diseases.

[3]  G. Ireton,et al.  Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis1 , 2008, The Journal of Immunology.

[4]  Xinchun Chen,et al.  Exploration of Novel Cellular and Serological Antigen Biomarkers in the ORFeome of Mycobacterium tuberculosis* , 2014, Molecular & Cellular Proteomics.

[5]  T. Eguale,et al.  Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. , 1999, The Journal of infectious diseases.

[6]  P. Blumberg,et al.  Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system. , 2013, Analytical biochemistry.

[7]  P. Andersen,et al.  Diagnosis of Tuberculosis Based on the Two Specific Antigens ESAT-6 and CFP10 , 2000, Clinical Diagnostic Laboratory Immunology.

[8]  J. Flynn,et al.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.

[9]  Claudine Médigue,et al.  Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. , 2002, Microbiology.

[10]  M. Pai,et al.  Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review , 2004 .

[11]  Yuanzi Hua,et al.  Cloning and expression of multiple integral membrane proteins from Mycobacterium tuberculosis in Escherichia coli , 2005, Protein science : a publication of the Protein Society.

[12]  P. Andersen,et al.  Immunological evaluation of novel Mycobacterium tuberculosis culture filtrate proteins. , 1999, FEMS immunology and medical microbiology.

[13]  S. Salzberg,et al.  Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains , 2002, Journal of bacteriology.

[14]  Andersen,et al.  Comparison of Antigen‐Specific T‐Cell Responses of Tuberculosis Patients using Complex or Single Antigens of Mycobacterium tuberculosis , 1998, Scandinavian journal of immunology.

[15]  M. Raška,et al.  Novel modification of growth medium enables efficient E. coli expression and simple purification of an endotoxin-free recombinant murine hsp70 protein. , 2009, Journal of microbiology and biotechnology.

[16]  T. M. Doherty.  New vaccines against tuberculosis , 2004 .

[17]  S. Cole,et al.  Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. , 2005, Microbiology.

[18]  G. Puzo,et al.  Lipoarabinomannans: from structure to biosynthesis. , 2003, Biochimie.

[19]  Q. Jin,et al.  Analysis of the Secretome and Identification of Novel Constituents from Culture Filtrate of Bacillus Calmette-Guérin Using High-resolution Mass Spectrometry* , 2013, Molecular & Cellular Proteomics.

[20]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[21]  Jian-Ping Chen,et al.  Serodiagnosis Efficacy and Immunogenicity of the Fusion Protein of Mycobacterium tuberculosis Composed of the 10-Kilodalton Culture Filtrate Protein, ESAT-6, and the Extracellular Domain Fragment of PPE68 , 2012, Clinical and Vaccine Immunology.

[22]  D. O'Kane,et al.  Bacterial luciferase alpha beta fusion protein is fully active as a monomer and highly sensitive in vivo to elevated temperature. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Philip L Felgner,et al.  Dynamic antibody responses to the Mycobacterium tuberculosis proteome , 2010, Proceedings of the National Academy of Sciences.

[24]  U. Kishore.  Target Pattern Recognition in Innate Immunity , 2009 .

[25]  S. Bhaskar,et al.  Isolation, purification and immunological characterization of novel low molecular weight protein antigen CFP 6 from culture filtrate of M. tuberculosis. , 2000, Vaccine.

[26]  G. Orefici,et al.  The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B‐DNA vaccine into a potent but non‐protective Th1 immune response in mice , 2007, Cellular microbiology.

[27]  C. Espitia,et al.  A 38-kD Mycobacterium tuberculosis antigen associated with infection. Its isolation and serologic evaluation. , 1989, Clinical and experimental immunology.

[28]  Cell Envelope Protein PPE68 Contributes to Mycobacterium tuberculosis RD1 Immunogenicity Independently of a 10-Kilodalton Culture Filtrate Protein and ESAT-6 , 2004, Infection and Immunity.

[29]  R. Wilkinson,et al.  Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial , 2015, The Lancet. Respiratory medicine.

[30]  F B Anspach,et al.  Endotoxin removal from protein solutions. , 2000, Journal of biotechnology.

[31]  H. Mollenkopf,et al.  Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors , 1998, European journal of immunology.

[32]  J. Bakken,et al.  Serum Cytokine Responses during Acute Human Granulocytic Ehrlichiosis , 2000, Clinical Diagnostic Laboratory Immunology.

[33]  C. F. von Reyn,et al.  Cellular Immune Responses to ESAT-6 Discriminate between Patients with Pulmonary Disease Due to Mycobacterium avium Complex and Those with Pulmonary Disease Due toMycobacterium tuberculosis , 1999, Clinical Diagnostic Laboratory Immunology.

[34]  Alimuddin Zumla,et al.  Biomarkers for tuberculosis disease activity, cure, and relapse. , 2009, The Lancet. Infectious diseases.

[35]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[36]  P. Nordlund,et al.  An efficient strategy for high‐throughput expression screening of recombinant integral membrane proteins , 2005, Protein science : a publication of the Protein Society.

[37]  G. Wolterink,et al.  The ACTH4–9 analog ORG 2766 ‘normalizes’ the changes in motor activities of rats elicited by housing and test conditions , 1987, Brain Research.